Immunoassays: A $27 Billion Market of Intrigue and Opportunity

The global market for lab-based immunoassays, inclusive of both infectious disease and non-infectious disease analytes and instruments, reached $27 billion in 2023 and is forecast to experience modest growth in the foreseeable future. The findings are based on data published in In Vitro Diagnostics Business Outlook, 2024, a bi-monthly newsletter focused on global IVD products […]

IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth

In Egypt, like many other countries, the elderly population is growing rapidly, increasing at a rate of 5.1% annually, which is more than double the growth rate of the total population. This demographic shift, coupled with a large rural population requiring satellite care and mobile services, poses significant challenges for the healthcare system, according to […]

Momentum in Multiplex Testing for IVD

Diagnostic testing is now a cornerstone of healthcare, assisting physicians in diagnosing conditions and prescribing treatments. Demand for in vitro diagnostic (IVD) testing has remained strong across various segments, with sales generally increasing throughout 2023. Global IVD market sales surpassed $100 billion in 2023, according to In Vitro Diagnostic (IVD) Trends and Market Update: March […]

Cancer, Obesity, Diabetes, and Cardiovascular Disease Drive South Korea’s IVD Investment

South Korea ranks as the fifth largest health market in the Asia Pacific region, following China, Japan, Australia, and India.. South Korea’s investment in healthcare, medical devices, and diagnostics is driven by the burden of obesity, diabetes, cardiovascular disease, and cancer. The country’s business environment for medical devices and equipment is favorable and streamlined for […]

How Globalization and Climate Change Impact COVID-19 and the IVD Market

COVID-19 hospitalizations in the U.S. have spiked in recent weeks amidst the advent of yet another new variant and the impending arrival of updated booster shots for a fall vaccination campaign. This late summer spike in infections comes after months of declines in COVID-related hospitalizations and deaths. The spike is poised to impact the in […]

IVD Trends 2023-2028: Emerging Growth Markets in Asia, Latin America, and the Middle East

In vitro diagnostic (IVD) testing is truly global as it has impacted every country in the world due to COVID-19 and it will continue to play an ever-increasing role in the practice of medicine. Social and economic events in selected countries will continue to influence the IVD market, but overall the IVD market plays an […]

IVD for Pets: A $2.7 Billion Global Market

The need for veterinary testing has grown in recent years, as the majority of U.S. households claim to have at least one pet in the family. This has created ample opportunity for the companion animal segment of the veterinary diagnostic market, which globally had sales of $2.7 billion in 2022. The findings are according to […]

Saudi Arabia IVD Market Rose to $605 Million in 2022, 3.8% CAGR Forecast

The market for in vitro diagnostics (IVDs) in Saudi Arabia, a young country in an aging world, reached an estimated $605 million in 2022, according to Kalorama Information’s 30-Country IVD Market Atlas. In 2022, the market was driven in part by COVID-19 testing, with about 44 million PCR COVID-19 tests performed through last August. Looking ahead, […]

WHO Reports Lowered Threat Level of COVID-19; What Does it Mean for Testing?

Three years and more than seven million casualties later, the COVID-19 pandemic is officially no longer a global health emergency, according to a recent statement by the World Health Organization (WHO). Dr. Tedros Adhanom Ghebreyesus, director general of WHO, announced COVID-19’s less severe designation in early May, though the decision had been carefully considered for […]

3 Trends Shaping Global $124 Billion In Vitro Diagnostic (IVD) Market

There’s no debate, in vitro diagnostics (IVDs) comprise a dynamic international industry with years of growth still ahead. The market already has more than $124 billion in worldwide sales and a presence in more than 20 key healthcare and medical segments ranging from molecular microbiology to infectious disease immunoassays to point-of-care (POC) to clinical chemistry. […]